Structural brain imaging in diabetes: A methodological perspective

European Journal of Pharmacology

Volumn 585, Issue 1, 2008, Pages 208-218

  Jongen, Cynthia ^a   Biessels, Geert Jan ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Brain; Cerebral atrophy; Diabetes; Image analysis; Magnetic resonance imaging; MRI; Segmentation; Voxel based morphometry; White matter hyperintensity

Indexed keywords

BRAIN ATROPHY; BRAIN DISEASE; BRAIN SIZE; DIABETES MELLITUS; HUMAN; IMAGE PROCESSING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; WHITE MATTER;

ATROPHY; BRAIN; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING;

EID: 42249106371     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.11.085     Document Type: Review

References (104)

1. Admiraal-Behloul F., van den Heuvel D.M.J., Olofsen H., van Osch M.J.P., van der Grond J., van Buchem M.A., and Reiber J.H.C. Fully automatic segmentation of white matter hyperintensities in MR images of the elderly. Neuroimage 28 (2005) 607-617
2. Akisaki T., Sakurai T., Takata T., Umegaki H., Araki A., Mizuno S., Tanaka S., Ohashi Y., Iguchi A., Yokono K., and Ito H. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab. Res. Rev. 22 (2006) 376-384
3. Anbeek P., Vincken K.L., van Bochove G.S., van Osch M.J.P., and van der Grond J. Probabilistic segmentation of brain tissue in MR imaging. Neuroimage 27 (2005) 795-804
4. Anbeek P., Vincken K.L., van Osch M.J.P., Bisschops R.H.C., and van der Grond J. Automatic segmentation of different-sized white matter lesions by voxel probability estimation. Med. Image Anal. 8 (2004) 205-215
5. Anderson V.M., Fernando K.T.M., Davies G.R., Rashid W., Frost C., Fox N.C., and Miller D.H. Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. J. Neuroimaging 17 (2007) 61-68
6. Ashburner J., and Friston K. Multimodal image coregistration and partitioning-a unified framework. Neuroimage 6 (1997) 209-217
7. Ashburner J., and Friston K.J. Voxel-based morphometry - the methods. Neuroimage 11 (2000) 805-821
8. Ashburner J., and Friston K.J. Why voxel-based morphometry should be used. Neuroimage 14 (2001) 1238-1243
9. Ashburner J., and Friston K.J. Morphometry. In: Frackowiak R.S.J., Friston K.J., Frith C., Dolan R., Price C.J., Zeki S., Ashburner J., and Penny W.D. (Eds). Human Brain Function. 2nd edition (2003), Academic Press 707-722
10. Ashburner J., and Friston K.J. Unified segmentation. Neuroimage 26 (2005) 839-851
11. Au R., Massaro J.M., Wolf P.A., Young M.E., Beiser A., Seshadri S., D'Agostino R.B., and DeCarli C. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch. Neurol. 63 (2006) 246-250
12. Biessels G.J., and Kappelle L.J. Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?. Biochem. Soc. Trans. 33 (2005) 1041-1044
13. Biessels G.J., Staekenborg S., Brunner E., Brayne C., and Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5 (2006) 64-74
14. Bookstein F.L. "Voxel-Based Morphometry" should not be used with imperfectly registered images. Neuroimage 14 (2001) 1454-1462
15. Boyes R.G., Rueckert D., Aljabar P., Whitwell J., Schott J.M., Hill D.L.G., and Fox N.C. Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integral. Neuroimage 32 (2006) 159-169
16. Bozzali M., and Cherubini A. Diffusion tensor MRI to investigate dementias: a brief review. Magn. Reson. Imaging 25 (2007) 969-977
17. Brands A.M., Biessels G.J., Kappelle L.J., de Haan E.H., de Valk H.W., Algra A., and Kessels R.P. Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dement. Geriatr. Cogn. Disord. 23 (2007) 343-350
18. Brands A.M.A., Biessels G.J., de Haan E.H.F., Kappelle L.J., and Kessels R.P.C. The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28 (2005) 726-735
19. Brands A.M.A., Kessels R.P.C., Hoogma R.P.L.M., Henselmans J.M.L., van der Beek Boter J., Kappelle L.J., de Haan E.H.F., and Biessels G.J. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes 55 (2006) 1800-1806
20. Bresciani L., Rossi R., Testa C., Geroldi C., Galluzzi S., Laakso M.P., Beltramello A., Soininen H., and Frisoni G.B. Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry. Aging Clin. Exp. Res. 17 (2005) 8-13
21. Bryan R.N., Manolio T.A., Schertz L.D., Jungreis C., Poirier V.C., Elster A.D., and Kronmal R.A. A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR Am. J. Neuroradiol. 15 (1994) 1625-1633
22. Carmichael O.T., Kuller L.H., Lopez O.L., Thompson P.M., Dutton R.A., Lu A., Lee S.E., Lee J.Y., Aizenstein H.J., Meltzer C.C., Liu Y., Toga A.W., and Becker J.T. Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis. Assoc. Disord. 21 (2007) 14-24
23. Carmichael O.T., Aizenstein H.A., Davis S.W., Becker J.T., Thompson P.M., Meltzer C.C., and Liu Y. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage 27 (2005) 979-990
24. Charlton R.A., Barrick T.R., McIntyre D.J., Shen Y., O'Sullivan M., Howe F.A., Clark C.A., Morris R.G., and Markus H.S. White matter damage on diffusion tensor imaging correlates with age-related cognitive decline. Neurology 66 (2006) 217-222
25. Cordonnier C., Al-Shahi Salman R., and Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 130 (2007) 1988-2003
26. Cukierman T., Gerstein H.C., and Williamson J.D. Cognitive decline and dementia in diabetes-systematic overview of prospective observational studies. Diabetologia 48 (2005) 2460-2469
27. Davatzikos C. Why voxel-based morphometric analysis should be used with great caution when characterizing group differences. Neuroimage 23 (2004) 17-20
28. de Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., and Breteler M.M. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann. Neurol. 52 (2002) 335-341
29. de Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., and Breteler M.M.B. Cerebral white matter lesions and cognitive function: the Rotterdam scan study. Ann. Neurol. 47 (2000) 145-151
30. de Leeuw F.E., de Groot J.C., Achten E., Oudkerk M., Ramos L.M., Heijboer R., Hofman A., Jolles J., van Gijn J., and Breteler M.M. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam scan study. J. Neurol. Neurosurg. Psychiatry 70 (2001) 9-14
31. DeCarli C.M., Fletcher E.P., Ramey V., Harvey D.P., and Jagust W.J.M. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 36 (2005) 50-55
32. Dejgaard A., Gade A., Larsson H., Balle V., Parving A., and Parving H.H. Evidence for diabetic encephalopathy. Diabet. Med. 8 (1991) 162-167
33. Du A.T., Schuff N., Chao L.L., Kornak J., Jagust W.J., Kramer J.H., Reed B.R., Miller B.L., Norman D., Chui H.C., and Weiner M.W. Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol. Aging 27 (2006) 733-740
34. Enzinger C., Fazekas F., Matthews P.M., Ropele S., Schmidt H., Smith S., and Schmidt R. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology 64 (2005) 1704-1711
35. Enzinger C., Fazekas F., Ropele S., and Schmidt R. Progression of cerebral white matter lesions - clinical and radiological considerations. J. Neurol. Sci. 257 1-2 (2007) 5-10
36. Ferguson S.C., Blane A., Perros P., McCrimmon R.J., Best J.J., Wardlaw J., Deary I.J., and Frier B.M. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52 (2003) 149-156
37. Ferguson S.C., Blane A., Wardlaw J., Frier B.M., Perros P., McCrimmon R.J., and Deary I.J. Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care 28 (2005) 1431-1437
38. Freeborough P.A., and Fox N.C. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans. Med. Imaging 16 (1997) 623-629
39. Garde E., Mortensen E.L., Krabbe K., Rostrup E., and Larsson H.B. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 356 (2000) 628-634
40. Gold S., Dziobek I., Sweat V., Tirsi A., Rogers K., Bruehl H., Tsui W., Richardson S., Javier E., and Convit A. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50 (2007) 711-719
41. Gomori J.M., Steiner I., Melamed E., and Cooper G. The assessment of changes in brain volume using combined linear measurements. Neuroradiology 26 (1984) 21-24
42. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N.A., Friston K.J., and Frackowiak R.S.J. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14 (2001) 21-36
43. Gouw A.A., van der Flier W.M., van Straaten E.C., Barkhof F., Ferro J.M., Baezner H., Pantoni L., Inzitari D., Erkinjuntti T., Wahlund L.O., Waldemar G., Schmidt R., Fazekas F., and Scheltens P. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J. Neurol. 253 (2006) 1189-1196
44. Gunter J.L., Shiung M.M., Manduca A., and Jack Jr. C.R. Methodological considerations for measuring rates of brain atrophy. J. Magn. Reson. Imaging 18 (2003) 16-24
45. Jeerakathil T., Wolf P.A., Beiser A., Massaro J., Seshadri S., D'Agostino R.B., and DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke 35 (2004) 1857-1861
46. Jongen C., van der Grond J., Kappelle L.J., Biessels G.-J., Viergever M.A., and Pluim J.P.W. Automated measurement of brain and white matter lesion volume in type 2 diabetes. Diabetologia 50 (2007) 1509-1516
47. Kapeller P., Barber R., Vermeulen R.J., Ader H., Scheltens P., Freidl W., Almkvist O., Moretti M., del S.T., Vaghfeldt P., Enzinger C., Barkhof F., Inzitari D., Erkinjunti T., Schmidt R., and Fazekas F. Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke 34 (2003) 441-445
48. Knopman D.S., Mosley T.H., Catellier D.J., Sharrett A.R., and for the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 65 (2005) 876-881
49. Korf E.S.C., van Straaten E.C.W., de Leeuw F.E., van der Flier W.M., Barkhof F., Pantoni L., Basile A.M., Inzitari D., Erkinjuntti T., Wahlund L.O., Rostrup E., Schmidt R., Fazekas F., and Scheltens P. Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet. Med. 24 (2007) 166-171
50. Korf E.S.C., White L.R., Scheltens P., and Launer L.J. Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study. Diabetes Care 29 (2006) 2268-2274
51. Kramer J.H., Mungas D., Reed B.R., Wetzel M.E., Burnett M.M., Miller B.L., Weiner M.W., and Chui H.C. Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 21 (2007) 412-418
52. Kuller L.H., Lopez O.L., Jagust W.J., Becker J.T., DeKosky S.T., Lyketsos C., Kawas C., Breitner J.C.S., Fitzpatrick A., and Dulberg C. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. Neurology 64 (2005) 1548-1552
53. Kuller L.H., Longstreth Jr. W.T., Arnold A.M., Bernick C., Nick Bryan R., Beauchamp Jr. N.J., and for the Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 35 (2004) 1821-1825
54. Last D., Alsop D.C., Abduljalil A.M., Marquis R.P., de Bazelaire C., Hu K., Cavallerano J., and Novak V. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 30 (2007) 1193-1199
55. Lobnig B.M., Kromeke O., Optenhostert-Porst C., and Wolf O.T. Hippocampal volume and cognitive performance in long-standing type 1 diabetic patients without macrovascular complications. Diabet. Med. 23 (2006) 32-39
56. Longstreth W.T., Arnold A.M., Manolio T.A., Burke G.L., Bryan N., Jungreis C.A., O'Leary D., Enright P.L., and Fried L. Clinical correlates of ventricular and sulcal size on cranial magnetic resonance imaging of 3,301 elderly people. The Cardiovascular Health Study. Collaborative Research Group. Neuroepidemiology 19 (2000) 30-42
57. Longstreth W.T., Arnold A.M., Beauchamp N.J., Manolio T.A., Lefkowitz D., Jungreis C., Hirsch C.H., O'Leary D.H., and Furberg C.D. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 36 (2005) 56-61
58. Lunetta M., Damanti A.R., Fabbri G., Lombardo M., Di M.M., and Mughini L. Evidence by magnetic resonance imaging of cerebral alterations of atrophy type in young insulin-dependent diabetic patients. J. Endocrinol. Invest. 17 (1994) 241-245
59. Manolio T.A., Kronmal R.A., Burke G.L., Poirier V., O'Leary D.H., Gardin J.M., Fried L.P., Steinberg E.P., and Bryan R.N. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke 25 (1994) 318-327
60. Manschot S.M., Brands A.M.A., van der Grond J., Kessels R.P.C., Algra A., Kappelle L.J., Biessels G.J., and on behalf of the Utrecht Diabetic Encephalopathy Study Group. Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55 (2006) 1106-1113
61. Manschot S.M., Biessels G.J., de Valk H.W., Algra A., Rutten G.E.H.M., van der Grond J., and Kappelle L.J. Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain MRI in patients with type 2 diabetes. Diabetologia 50 11 (2007) 2388-2397
62. Mäntylä R., Erkinjuntti T., Salonen O., Aronen H.J., Peltonen T., Pohjasvaara T., and Standertskjold-Nordenstam C.G. Variable agreement between visual rating scales for white matter hyperintensities on MRI. Comparison of 13 rating scales in a poststroke cohort. Stroke 28 (1997) 1614-1623
63. Musen G., Lyoo I.K., Sparks C.R., Weinger K., Hwang J., Ryan C.M., Jimerson D.C., Hennen J., Renshaw P.F., and Jacobson A.M. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55 (2006) 326-333
64. Nakamura Y., Takahashi M., Kitaguti M., Imaoka H., Kono N., and Tarui S. Abnormal brainstem evoked potentials in diabetes mellitus. Evoked potential testings and magnetic resonance imaging. Electromyogr. Clin. Neurophysiol. 31 (1991) 243-249
65. Novak V., Last D., Alsop D.C., Abduljalil A.M., Hu K., Lepicovsky L., Cavallerano J., and Lipsitz L.A. Cerebral blood flow velocity and periventricular white matter hyperintensities in type 2 diabetes. Diabetes Care 29 (2006) 1529-1534
66. Pantoni L., Simoni M., Pracucci G., Schmidt R., Barkhof F., and Inzitari D. Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced?. Stroke 33 (2002) 2827-2833
67. Payne M.E., Fetzer D.L., MacFall J.R., Provenzale J.M., Byrum C.E., and Krishnan K.R. Development of a semi-automated method for quantification of MRI gray and white matter lesions in geriatric subjects. Psychiatry Res. Neuroimaging 115 (2002) 63-77
68. Perros P., Deary I.J., Sellar R.J., Best J.J., and Frier B.M. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20 (1997) 1013-1018
69. Prins N.D., van Straaten E.C., van Dijk E.J., Simoni M., van Schijndel R.A., Vrooman H.A., Koudstaal P.J., Scheltens P., Breteler M.M., and Barkhof F. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 62 (2004) 1533-1539
70. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
71. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., Steinling M., and Valk J. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci. 114 (1993) 7-12
72. Scheltens P., Launer L.J., Barkhof F., Weinstein H.C., and van Gool W.A. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. J. Neurol. 242 (1995) 557-560
73. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P., Kuiper M., Steinling M., Wolters E.C., and Valk J. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 55 (1992) 967-972
74. Scheltens P., Pasquier F., Weerts J.G., Barkhof F., and Leys D. Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur. Neurol. 37 (1997) 95-99
75. Scheltens P., Erkinjunti T., Leys D., Wahlund L.O., Inzitari D., del Ser T., Pasquier F., Barkhof F., Mäntylä R., Bowler J., Wallin A., Ghika J., Fazekas F., and Pantoni L. White matter changes on CT and MRI: an overview of visual rating scales. Eur. Neurol. 39 (1998) 80-89
76. Schmidt R., Enzinger C., Ropele S., Schmidt H., and Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 361 (2003) 2046-2048
77. Senjem M.L., Gunter J.L., Shiung M.M., Petersen R.C., and Jack J. Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage 26 (2005) 600-608
78. Smith S.M., De Stefano N., Jenkinson M., and Matthews P.M. Normalized accurate measurement of longitudinal brain change. J. Comput. Assist. Tomogr. 25 (2001) 466-475
79. Smith S.M., Rao A., De Stefano N., Jenkinson M., Schott J.M., Matthews P.M., and Fox N.C. Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: cross-validation of BSI, SIENA and SIENAX. Neuroimage 36 (2007) 1200-1206
80. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., and De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17 (2002) 479-489
81. Strachan M.W., Deary I.J., Ewing F.M., and Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20 (1997) 438-445
82. Taylor W.D., MacFall J.R., Provenzale J.M., Payne M.E., McQuoid D.R., Steffens D.C., and Krishnan K.R. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. AJR Am. J. Roentgenol. 181 (2003) 571-576
83. Taylor W.D., MacFall J.R., Steffens D.C., Payne M.E., Provenzale J.M., and Krishnan K.R. Localization of age-associated white matter hyperintensities in late-life depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 539-544
84. Taylor W.D., MacFall J.R., Payne M.E., McQuoid D.R., Steffens D.C., Provenzale J.M., and Krishnan R.R. Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res. Neuroimaging 139 (2005) 1-7
85. Testa C., Laakso M.P., Sabattoli F., Rossi R., Beltramello A., Soininen H., and Frisoni G.B. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease. J. Magn. Reson. Imaging 19 (2004) 274-282
86. Tiehuis A.M., Vincken K.L., Mali W.P.Th.M., Kappelle L.J., Anbeek P., Algra A., and Biessels G.J. Automated and visual scoring methods of cerebral white matter hyperintensities; relation with age and cognitive function. Cerebrovasc. Dis. 25 1-2 (2004) 59-66
87. Tisserand D.J., Pruessner J.C., Sanz Arigita E.J., van Boxtel M.P.J., Evans A.C., Jolles J., and Uylings H.B.M. Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry. Neuroimage 17 (2002) 657-669
88. van den Heuvel D.M.J., Admiraal-Behloul F., ten Dam V.H., Olofsen H., Bollen E.L., Murray H.M., Blauw G.J., Westendorp R.G., de Craen A.J., and van Buchem M.A. Different progression rates for deep white matter hyperintensities in elderly men and women. Neurology 63 (2004) 1699-1701
89. van den Heuvel D.M., ten D.V., de Craen A.J., Admiraal-Behloul F., van Es A.C., Palm W.M., Spilt A., Bollen E.L., Blauw G.J., Launer L., Westendorp R.G., and van Buchem M.A. Measuring longitudinal white matter changes: comparison of a visual rating scale with a volumetric measurement. AJNR Am. J. Neuroradiol. 27 (2006) 875-878
90. van den Heuvel D.M.J., ten Dam V.H., de Craen A.J.M., Admiraal-Behloul F., Olofsen H., Bollen E.L.E.M., Jolles J., Murray H.M., Blauw G.J., Westendorp R.G.J., and van Buchem M.A. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J. Neurol. Neurosurg. Psychiatry 77 (2006) 149-153
91. van Dijk E.J., Breteler M.M.B., Schmidt R., Berger K., Nilsson L.G., Oudkerk M., Pajak A., Sans S., de Ridder M., Dufouil C., Fuhrer R., Giampaoli S., Launer L.J., Hofman A., and for the CASCADE Consortium. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 44 (2004) 625-630
92. van Harten B., de Leeuw F.E., Weinstein H.C., Scheltens P., and Biessels G.J. Brain imaging in patients with diabetes: a systematic review. Diabetes Care 29 (2006) 2539-2548
93. van Harten B., Oosterman J.M., Potter van Loon B.J., Scheltens P., and Weinstein H.C. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur. Neurol. 57 (2007) 70-74
94. van Harten B., Oosterman J., Muslimovic D., van Loon B.-J.P., Scheltens P., and Weinstein H.C. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 36 (2007) 164-170
95. van Straaten E.C., Fazekas F., Rostrup E., Scheltens P., Schmidt R., Pantoni L., Inzitari D., Waldemar G., Erkinjuntti T., Mantyla R., Wahlund L.O., and Barkhof F. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37 (2006) 836-840
96. Wahlund L.O., Julin P., Johansson S.E., and Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J. Neurol. Neurosurg. Psychiatry 69 (2000) 630-635
97. Wardlaw J.M., Ferguson K.J., and Graham C. White matter hyperintensities and rating scales-observer reliability varies with lesion load. J. Neurol. 251 (2004) 584-590
98. Wells W.M., Grimson W.E.L., Kikinis R., and Jolesz F.A. Adaptive segmentation of MRI data. IEEE Trans. Med. Imaging 15 (1996) 429-442
99. Wen W., and Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. Neuroimage 22 (2004) 144-154
100. Wen W., and Sachdev P.S. Extent and distribution of white matter hyperintensities in stroke patients: the Sydney Stroke Study. Stroke 35 (2004) 2813-2819
101. Wen W., Sachdev P.S., Chen X., and Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 29 (2006) 1031-1039
102. Wessels A., Simsek S., Remijnse P., Veltman D., Biessels G., Barkhof F., Scheltens P., Snoek F., Heine R., and Rombouts S. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49 (2006) 2474-2480
103. Whitwell J.L., Przybelski S.A., Weigand S.D., Knopman D.S., Boeve B.F., Petersen R.C., and Jack Jr. C.R. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130 (2007) 1777-1786
104. Zhang Y., Brady M., and Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 20 (2001) 45-57